Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0001193125-26-259526

Options or other derivatives

  • Director acquired 19,676 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Walsh Kathleen E Director 2026-06-03 Grant or award · Stock Option (Right to Buy) +19,676 19,676 D: show line 1 in the form
Loading xslF345X06/ownership.xml…